NYSE:MET - MetLife Stock Price, Price Target & More

$47.49 +0.05 (+0.11 %)

(As of 04/22/2018 10:05 AM ET)

Previous Close$47.49

Today's Range$46.9750 - $47.72

52-Week Range$43.38 - $55.91

Volume4.38 million shs

Average Volume5.51 million shs

Market Capitalization$49.23 billion

P/E Ratio10.55

Dividend Yield3.37%

Beta1.24

About MetLife (NYSE:MET)

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Life insurance

Sub-IndustryLife & Health Insurance

SectorFinance

SymbolNYSE:MET

CUSIP59156R10

Webwww.metlife.com

Phone212-578-9500

Debt

Debt-to-Equity Ratio0.29%

Current Ratio0.15%

Quick Ratio0.15%

Price-To-Earnings

Trailing P/E Ratio10.55

Forward P/E Ratio9.67

P/E Growth0.84

Sales & Book Value

Annual Sales$62.09 billion

Price / Sales0.79

Cash Flow$4.4760 per share

Price / Cash10.61

Book Value$55.94 per share

Price / Book0.85

Profitability

EPS (Most Recent Fiscal Year)$4.50

Net Income$4.01 billion

Net Margins5.69%

Return on Equity8.59%

Return on Assets0.66%

Miscellaneous

Employees49,000

Outstanding Shares1,036,640,000

How to Become a New Pot Stock Millionaire

MetLife (NYSE:MET) Frequently Asked Questions

What is MetLife's stock symbol?

MetLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does MetLife pay dividends? What is the dividend yield for MetLife?

MetLife announced a quarterly dividend on Friday, January 5th. Stockholders of record on Monday, February 5th will be given a dividend of $0.40 per share on Tuesday, March 13th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.37%. The ex-dividend date is Friday, February 2nd. View MetLife's Dividend History.

How were MetLife's earnings last quarter?

MetLife (NYSE:MET) posted its earnings results on Tuesday, February, 13th. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.05 by $0.41. The financial services provider had revenue of $15.79 billion for the quarter, compared to analysts' expectations of $15.89 billion. MetLife had a net margin of 5.69% and a return on equity of 8.59%. During the same period in the prior year, the firm posted $1.28 earnings per share. View MetLife's Earnings History.

When is MetLife's next earnings date?

MetLife is scheduled to release their next quarterly earnings announcement on Tuesday, May, 1st 2018. View Earnings Estimates for MetLife.

What guidance has MetLife issued on next quarter's earnings?

MetLife issued an update on its fourth quarter earnings guidance on Monday, January, 29th. The company provided earnings per share (EPS) guidance of $1.07-1.14 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.07.

What price target have analysts set for MET?

18 equities research analysts have issued 1-year price targets for MetLife's shares. Their forecasts range from $47.00 to $78.00. On average, they anticipate MetLife's stock price to reach $56.6667 in the next twelve months. View Analyst Ratings for MetLife.

What are Wall Street analysts saying about MetLife stock?

Here are some recent quotes from research analysts about MetLife stock:

1. According to Zacks Investment Research, "MetLife’s shares underperformed its industry in a year's time. The company's efforts to streamline its business (for the past many years), only to focus on core business, are really impressive. Its revenues grew in 2017 after declining in two years prior to that. Revenues are expected to grow in 2018 on the back of mid single-digit sales growth in Asia and EMEA,rise in operating premiums, fees and other revenues in its Group Benefits segment and an increase in net investment income owing to rising interest rates. Its strong international operations and disciplined capital management should drive long-term growth. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 4.3% upward over the last 90 days. Nevertheless, exposure to catastrophe losses and investment in efficiency programs will pressrize margins." (4/3/2018)
2. Wells Fargo analysts commented, "We hosted investor meetings with MetLife today (March 15) at the company’s NYC headquarters. From MET were Steven Kandarian, President, Chairman & CEO; John Hele, EVP & CFO; and John Hall, SVP & Head of IR. Investors were focused on MET’s material weaknesses (MW), unit cost initiative (UCI), long term care reserves, Brighthouse exchange offer, and reinsurance opportunities with MetLife Holdings. To us, the investment case for MET remains unchanged – faster growth in less capital intensive and less volatile businesses should lower the company’s cost of equity, which in turn should allow MetLife to achieve a higher ROE spread as well as a higher valuation multiple. We reiterate our Outperform rating on MET, which is also our top pick." (3/16/2018)

Who are some of MetLife's key competitors?

Some companies that are related to MetLife include China Life Insurance (LFC), AXA (AXAHY), Prudential (PUK), Prudential Financial (PRU), Manulife Financial (MFC), Swiss Re (SSREY), Aviva (AVVIY), Sun Life Financial (SLF), Hannover Re (HVRRY), Old Mutual (ODMTY), Lincoln Financial Group (LNC), Legal & General (LGEN), AMP (AMP), Aegon (AEG), Reinsurance Group of America (RGA), Torchmark (TMK), Athene (ATH) and Voya Financial (VOYA).

Who are MetLife's key executives?

MetLife's management team includes the folowing people:

Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)
Mr. John Carroll Ramsey Hele, Exec. VP & CFO (Age 60)
Mr. Steven Jeffery Goulart, Chief Investment Officer & Exec. VP (Age 59)
Mr. Martin J. Lippert, Head of Global Technology & Operations and Exec. VP (Age 58)
Ms. Kirstie Traas, Head of Operations

Has MetLife been receiving favorable news coverage?

Headlines about MET stock have trended somewhat positive on Sunday, according to Accern. The research group identifies positive and negative media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. MetLife earned a media sentiment score of 0.20 on Accern's scale. They also gave news articles about the financial services provider an impact score of 45.38 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are MetLife's major shareholders?

MetLife's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (14.90%). Company insiders that own MetLife stock include Christopher G Townsend, Frans Hijkoop, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for MetLife.

How do I buy shares of MetLife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MetLife's stock price today?

One share of MET stock can currently be purchased for approximately $47.49.

How big of a company is MetLife?

MetLife has a market capitalization of $49.23 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. MetLife employs 49,000 workers across the globe.

How can I contact MetLife?

MetLife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

MarketBeat Community Rating for MetLife (MET)

Community Ranking:		3.2 out of 5 ( )
Outperform Votes:		678 (Vote Outperform)
Underperform Votes:		391 (Vote Underperform)
Total Votes:		1,069

MarketBeat's community ratings are surveys of what our community members think about MetLife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.

MetLife (NYSE:MET) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

18 Wall Street analysts have issued ratings and price targets for MetLife in the last 12 months. Their average twelve-month price target is $56.6667, suggesting that the stock has a possible upside of 19.32%. The high price target for MET is $78.00 and the low price target for MET is $47.00. There are currently 1 sell rating, 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Buy
Consensus Rating Score:	2.39	2.38	2.41	2.50
Ratings Breakdown:	1 Sell Rating(s) 9 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 8 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 9 Hold Rating(s) 6 Buy Rating(s) 1 Strong Buy Rating(s)	1 Sell Rating(s) 7 Hold Rating(s) 7 Buy Rating(s) 1 Strong Buy Rating(s)
Consensus Price Target:	$56.6667	$58.0769	$57.9164	$57.7736
Price Target Upside:	19.32% upside	23.67% upside	14.55% upside	10.30% upside

MetLife (NYSE:MET) Consensus Price Target History

Price Target History for MetLife (NYSE:MET)

MetLife (NYSE:MET) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/5/2018	Sandler O'Neill	Set Price Target	Hold	$47.00	Low
4/5/2018	Morgan Stanley	Lower Price Target	Equal Weight -> Equal Weight	$58.00 -> $56.00	Low
3/26/2018	Bank of America	Initiated Coverage	Neutral	$50.00	High
3/26/2018	Atlantic Securities	Upgrade	Neutral -> Overweight		High
3/16/2018	Wells Fargo	Reiterated Rating	Buy	$60.00	Low
3/2/2018	UBS	Reiterated Rating	Neutral -> Neutral	$52.00 -> $51.00	Low
2/23/2018	Keefe, Bruyette & Woods	Reiterated Rating	Buy	$56.00	Low
1/31/2018	Goldman Sachs	Reiterated Rating	Conviction-Buy -> Buy		High
1/2/2018	Deutsche Bank	Initiated Coverage	Hold	$55.00	Medium
11/6/2017	B. Riley	Reiterated Rating	Neutral		N/A
11/6/2017	Argus	Boost Price Target	Buy	$55.00 -> $60.00	N/A
11/3/2017	Royal Bank of Canada	Reiterated Rating	Outperform -> Outperform	$56.00 -> $60.00	N/A
10/10/2017	FBR & Co	Downgrade	Buy -> Neutral	$53.00 -> $52.00	N/A
8/28/2017	Credit Suisse Group	Reiterated Rating	Neutral	$64.00 -> $53.00	Low
8/16/2017	Langen Mcalenn	Reiterated Rating	Buy		Medium
8/11/2017	Barclays	Lower Price Target	Overweight	$67.00 -> $60.00	Low
7/24/2017	JPMorgan Chase	Initiated Coverage	Hold	$78.00	Low
7/7/2017	Citigroup	Set Price Target	Sell	$51.00	Low
12/9/2016	Standpoint Research	Downgrade	Buy -> Hold		N/A
7/6/2016	Evercore ISI	Initiated Coverage	Buy	$52.00	N/A

(Data available from 4/22/2016 forward)

MetLife (NYSE:MET) Earnings History and Estimates Chart

Earnings by Quarter for MetLife (NYSE:MET)

MetLife (NYSE:MET) Earnings Estimates

2018 EPS Consensus Estimate: $5.29
2019 EPS Consensus Estimate: $5.47

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$1.10	$1.44	$1.23
Q2 2018	2	$1.18	$1.43	$1.31
Q3 2018	2	$1.28	$1.47	$1.38
Q4 2018	2	$1.34	$1.42	$1.38
Q1 2019	1	$1.35	$1.35	$1.35
Q2 2019	1	$1.29	$1.29	$1.29
Q3 2019	1	$1.38	$1.38	$1.38
Q4 2019	1	$1.45	$1.45	$1.45

MetLife (NYSE MET) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/1/2018		$1.18					N/A
2/13/2018	Q4 2017	$1.05	$0.64	$15.8867 billion	$15.7890 billion	View	N/A
11/1/2017	Q3 2017	$0.90	$1.09	$15.4685 billion	$16.1040 billion	View	N/A
8/2/2017	Q2 2017	$1.28	$1.30	$17.1129 billion	$17.3870 billion	View	Listen
5/3/2017	Q1 2017	$1.27	$1.46	$17.0216 billion	$16.2690 billion	View	Listen
2/1/2017	Q416	$1.34	$1.28	$17.34 billion	$12.0760 billion	View	Listen
11/2/2016	Q316	$1.14	$1.28	$17.03 billion	$17.70 billion	View	Listen
8/3/2016	Q216	$1.35	$0.83	$17.35 billion	$17.00 billion	View	Listen
5/4/2016	Q116	$1.38	$1.20	$17.16 billion	$16.6110 billion	View	Listen
2/3/2016	Q415	$1.36	$1.23	$17.61 billion	$17.1110 billion	View	Listen
11/4/2015	Q315	$0.76	$0.62	$17.77 billion	$17.9670 billion	View	Listen
7/29/2015	Q215	$1.47	$1.56	$17.69 billion	$17.40 billion	View	Listen
5/6/2015	Q115	$1.41	$1.44	$17.53 billion	$17.03 billion	View	Listen
2/11/2015	Q414	$1.37	$1.38	$18.18 billion	$18.25 billion	View	Listen
10/29/2014	Q314	$1.38	$1.60	$17.65 billion	$17.9180 billion	View	Listen
7/30/2014	Q214	$1.41	$1.39	$17.54 billion	$17.8010 billion	View	Listen
4/30/2014	Q114	$1.40	$1.37	$17.4991 billion	$17.1160 billion	View	Listen
2/13/2014	Q413	$1.30	$1.37	$17.43 billion	$18.3820 billion	View	Listen
10/31/2013	Q313	$1.34	$1.34	$17.23 billion	$16.90 billion	View	Listen
7/31/2013	Q2 2013	$1.33	$1.44	$17.31 billion	$17.04 billion	View	Listen
5/1/2013	Q1 2013	$1.31	$1.48	$17.3423 billion	$17.00 million	View	Listen
2/13/2013	Q4 2012	$1.18	$1.25	$17.25 billion	$18.36 billion	View	Listen
10/31/2012		$1.28	$1.32			View	N/A
8/1/2012		$1.25	$1.33			View	N/A
4/26/2012		$1.26	$1.37			View	N/A
2/14/2012		$1.25	$1.31			View	N/A
10/27/2011		$1.09	$1.11			View	N/A
7/28/2011		$1.13	$1.13			View	N/A
5/5/2011		$1.26	$1.33			View	N/A
2/9/2011		$1.10	$1.14			View	N/A
10/28/2010	Q3 2010	$1.03	$0.99			View	N/A
7/29/2010	Q2 2010	$1.00	$1.23			View	N/A
4/29/2010	Q1 2010	$0.97	$1.01			View	N/A
2/2/2010	Q4 2009	$0.95	$0.96			View	N/A
10/29/2009	Q3 2009	$0.86	$0.87			View	N/A
7/30/2009	Q2 2009	$0.70	$0.88			View	N/A
4/30/2009	Q1 2009	$0.47	$0.20			View	N/A
2/3/2009	Q4 2008	$0.14	$0.19			View	N/A
10/29/2008	Q3 2008	$0.89	$0.88			View	N/A
7/29/2008	Q2 2008	$1.51	$1.30			View	N/A
5/1/2008	Q1 2008	$1.48	$1.52			View	N/A
2/6/2008	Q4 2007	$1.43	$1.60			View	N/A

(Earnings results data provided by Zacks Investment Research)

MetLife (NYSE:MET) Dividend Information

MetLife pays an annual dividend of $1.60 per share, with a dividend yield of 3.37%. MET's most recent quarterly dividend payment was Tuesday, March 13. The company has grown its dividend for the last 5 consecutive years and is increasing its dividend by an average of 6.50% each year. MetLife pays out 35.56% of its earnings out as a dividend.

Most Recent Dividend:	3/13/2018
Annual Dividend:	$1.60
Dividend Yield:	3.37%
Dividend Growth:	6.50% (3 Year Average)
Payout Ratio:	35.56% (Trailing 12 Months of Earnings) 32.59% (Based on This Year's Estimates) 29.52% (Based on Next Year's Estimates)
Track Record:	5 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for MetLife (NYSE:MET)

MetLife (NYSE:MET) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/5/2018	quarterly	$0.40	3.08%	2/2/2018	2/5/2018	3/13/2018
10/24/2017	quarterly	$0.40	2.97%	11/3/2017	11/6/2017	12/13/2017
7/7/2017	quarterly	$0.40	2.85%	8/3/2017	8/7/2017	9/13/2017
4/25/2017	quarterly	$0.40	3.08%	5/4/2017	5/8/2017	6/13/2017
1/6/2017	quarterly	$0.40	2.98%	2/2/2017	2/6/2017	3/13/2017
10/25/2016	quarterly	$0.40	3.41%	11/3/2016	11/7/2016	12/13/2016
7/7/2016	quarterly	$0.40	4.08%	8/4/2016	8/8/2016	9/13/2016
4/26/2016	quarterly	$0.40	3.42%	5/5/2016	5/9/2016	6/13/2016
10/27/2015	quarterly	$0.3750	2.93%	11/4/2015	11/6/2015	12/11/2015
7/7/2015	quarterly	$0.3750	2.76%	8/5/2015	8/7/2015	9/11/2015
4/28/2015	quarterly	$0.3750	2.88%	5/7/2015	5/11/2015	6/12/2015
1/6/2015	quarterly	$0.35	2.73%	2/4/2015	2/6/2015	3/13/2015
10/28/2014	quarterly	$0.35	2.68%	11/5/2014	11/7/2014	12/12/2014
7/7/2014	quarterly	$0.35	2.5%	8/6/2014	8/8/2014	9/12/2014
4/22/2014	quarterly	$0.35	2.7%	5/7/2014	5/9/2014	6/13/2014
1/6/2014	quarterly	$0.2750	2.06%	2/4/2014	2/6/2014	3/13/2014
10/22/2013	quarterly	$0.2750	2.28%	11/6/2013	11/8/2013	12/13/2013
6/25/2013	quarterly	$0.2750	2.42%	8/7/2013	8/9/2013	9/13/2013
4/23/2013	quarterly	$0.2750	2.87%	5/7/2013	5/9/2013	6/13/2013
1/4/2013	quarterly	$0.1850	2.07%	2/4/2013	2/6/2013	3/13/2013

(Data available from 1/1/2013 forward)

MetLife (NYSE MET) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.32%
Institutional Ownership Percentage: 77.68%

Insider Trading History for MetLife (NYSE:MET)

Institutional Ownership by Quarter for MetLife (NYSE:MET)

MetLife (NYSE MET) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/6/2017	Christopher G Townsend	Insider	Sell	55,712	$54.29	$3,024,604.48	25,181
11/3/2017	Christopher G Townsend	Insider	Sell	82,731	$54.60	$4,517,112.60	49,660
3/22/2017	James M Kilts	Director	Buy	17,205	$51.13	$879,691.65	59,443
3/1/2017	James M Kilts	Director	Buy	2,795	$54.17	$151,405.15	41,951
12/23/2016	Peter M Carlson	EVP	Sell	23,636	$54.32	$1,283,907.52	39,914
12/1/2016	Frans Hijkoop	EVP	Sell	14,997	$56.18	$842,531.46	70,560
11/9/2016	Frans Hijkoop	EVP	Sell	56,250	$51.48	$2,895,750.00	111,813
11/1/2016	Maria R Morris	EVP	Sell	2,200	$47.33	$104,126.00	109,809
10/4/2016	Maria R Morris	EVP	Sell	8,800	$45.00	$396,000.00	116,409
8/2/2016	Maria R Morris	EVP	Sell	2,000	$42.96	$85,920.00	109,273
7/1/2016	Maria R Morris	EVP	Sell	2,000	$39.43	$78,860.00	109,273
6/1/2016	Maria R Morris	EVP	Sell	4,200	$45.15	$189,630.00	108,932
5/2/2016	Maria R Morris	EVP	Sell	4,200	$45.46	$190,932.00	108,932
4/18/2016	Maria R Morris	EVP	Sell	2,200	$45.00	$99,000.00	109,132
3/30/2016	Maria R Morris	EVP	Sell	4,400	$45.00	$198,000.00	111,332
3/1/2016	Maria R Morris	EVP	Sell	2,000	$39.97	$79,940.00	108,623
2/1/2016	Maria R. Morris	EVP	Sell	2,000	$44.31	$88,620.00	89,562
12/2/2015	Kenton J Sicchitano	Director	Sell	9,503	$50.78	$482,562.34	26,947
12/1/2015	Maria R. Morris	EVP	Sell	4,200	$51.23	$215,166.00	89,275
11/2/2015	Maria R. Morris	EVP	Sell	4,200	$50.60	$212,520.00	89,275
10/1/2015	Maria R. Morris	EVP	Sell	4,200	$47.22	$198,324.00	89,275
9/1/2015	Maria R. Morris	EVP	Sell	4,200	$48.42	$203,364.00	89,000
7/1/2015	Maria R Morris	EVP	Sell	6,200	$57.00	$353,400.00
6/22/2015	Steven A Kandarian	CEO	Sell	17,500	$57.12	$999,600.00
6/2/2015	Maria R Morris	EVP	Sell	6,200	$52.41	$324,942.00
5/1/2015	Maria R Morris	EVP	Sell	4,200	$51.72	$217,224.00
4/1/2015	Maria R Morris	EVP	Sell	4,200	$50.24	$211,008.00
3/6/2015	Maria R Morris	EVP	Sell	2,000	$53.00	$106,000.00
3/2/2015	Maria R Morris	EVP	Sell	4,200	$50.63	$212,646.00
2/2/2015	Maria R Morris	EVP	Sell	4,200	$46.85	$196,770.00
1/2/2015	Maria R Morris	EVP	Sell	4,200	$54.58	$229,236.00
10/28/2014	Maria R Morris	EVP	Sell	18,300	$51.74	$946,842.00
6/12/2014	Peter M Carlson	CAO	Sell	91,625	$54.29	$4,974,321.25
3/6/2014	Beth Hirschhorn	EVP	Sell	30,594	$52.44	$1,604,349.36	34,216
12/24/2013	Maria Morris	EVP	Sell	12,000	$53.08	$636,960.00	65,844
8/14/2013	John Keane	Director	Sell	1,210	$49.57	$59,979.70	29,957
8/5/2013	William Wheeler	Insider	Sell	40,000	$50.92	$2,036,800.00	230,867
5/29/2013	Beth Hirschhorn	EVP	Sell	20,764	$44.18	$917,353.52
5/8/2013	Kenton J Sicchitano	Director	Sell	1,536	$40.77	$62,622.72

(Data available from 1/1/2013 forward)

MetLife (NYSE MET) News Headlines

Source:

Date	Headline
	What Prudential Has in Mind for US Workplace Solutions finance.yahoo.com - April 21 at 8:09 AM
	BRIEF-Metlife Names Susan Greenwell As Head Of Global Government Relations www.reuters.com - April 20 at 5:31 PM
	MetLife Names Susan Greenwell as Head of Global Government Relations www.businesswire.com - April 20 at 5:31 PM
	ValuEngine Upgrades MetLife (MET) to "Strong-Buy" www.americanbankingnews.com - April 20 at 1:19 PM
	Prudential’s Individual Annuities and Life Business finance.yahoo.com - April 20 at 8:12 AM
	Free Research Reports on These Insurance Stocks -- Lincoln National, Manulife Financial, MetLife, and Torchmark www.prnewswire.com - April 20 at 6:10 AM
	MetLife (MET) Receives Average Recommendation of "Hold" from Brokerages www.americanbankingnews.com - April 20 at 1:40 AM
	A Look at the PGIM Ultra-Short Bond ETF finance.yahoo.com - April 19 at 5:50 PM
	New York governor presses banks, insurers to weigh risk of NRA ties finance.yahoo.com - April 19 at 5:50 PM
	MetLife (MET) Given "Buy" Rating at Royal Bank of Canada www.americanbankingnews.com - April 18 at 11:54 PM
	BRIEF-Metlife Investment Management Reaches $11.2 Bln In Private Debt Origination In 2017 www.reuters.com - April 18 at 5:54 PM
	MetLife Investment Management Reaches a Record $11.2 Billion in Private Debt Origination in 2017 finance.yahoo.com - April 18 at 5:54 PM
	Collab Winners Are 'Building a Long-Term Relationship' with MetLife www.businesswire.com - April 17 at 8:14 AM
	Collab Winners Are ‘Building a Long-Term Relationship’ with MetLife finance.yahoo.com - April 17 at 8:14 AM
	Analysts Set Expectations for MetLife's Q1 2018 Earnings (MET) www.americanbankingnews.com - April 17 at 6:51 AM
	MetLife (MET) Rating Lowered to Sell at BidaskClub www.americanbankingnews.com - April 16 at 5:55 PM
	Employers and Employees Embrace Automation but Fear Loss of Workplace Humanity finance.yahoo.com - April 16 at 5:36 PM
	MetLife (MET) Stock Rating Reaffirmed by Keefe, Bruyette & Woods www.americanbankingnews.com - April 13 at 8:53 PM
	Langen Mcalenn Comments on MetLife's Q1 2018 Earnings (MET) www.americanbankingnews.com - April 12 at 7:25 AM
	Argus Cuts MetLife (MET) Price Target to $55.00 www.americanbankingnews.com - April 11 at 10:42 PM
	MetLife (MET) Upgraded by BidaskClub to "Hold" www.americanbankingnews.com - April 11 at 9:31 PM
	MetLife (MET) Downgraded by Zacks Investment Research to Sell www.americanbankingnews.com - April 11 at 8:27 PM
	MetLife Foundation Awards $2.5 Million Grant to The Financial Clinic to Bring Financial Security to Jobseekers Nationally globenewswire.com - April 11 at 5:45 PM
	MetLife (MET) Upgraded to Strong-Buy at ValuEngine www.americanbankingnews.com - April 10 at 7:51 PM
	TheStreet Downgrades MetLife (MET) to C+ www.americanbankingnews.com - April 9 at 9:46 PM
	MetLife Foundation and Verb Launch Competition to Improve Financial Health in the US www.businesswire.com - April 9 at 5:31 PM
	MetLife (MET) Stock Rating Lowered by ValuEngine www.americanbankingnews.com - April 7 at 8:50 PM
	MetLife (MET) Lowered to "Neutral" at FBR & Co www.americanbankingnews.com - April 7 at 6:04 PM
	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MetLife, Inc. And Reminds Investors With Losses To Contact The Firm finance.yahoo.com - April 6 at 5:50 PM
	MetLife's Matus Says the U.S. Has Been Creating Excess Jobs finance.yahoo.com - April 6 at 5:50 PM
	MetLife (MET) Now Covered by Goldman Sachs www.americanbankingnews.com - April 6 at 4:46 PM
	MetLife (MET) Rating Lowered to Hold at ValuEngine www.americanbankingnews.com - April 6 at 12:00 PM
	METLIFE 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline ... www.businesswire.com - April 6 at 8:13 AM
	FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MetLife, Inc. (MET) and Lead Plaintiff Deadline: April 6, 2018 finance.yahoo.com - April 5 at 5:26 PM
	DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MetLife, Inc. And Reminds Investors With Losses To Contact The Firm finance.yahoo.com - April 5 at 5:26 PM
	Sandler O'Neill Reiterates "$47.00" Price Target for MetLife (MET) www.americanbankingnews.com - April 5 at 3:30 PM
	MetLife (MET) PT Lowered to $56.00 www.americanbankingnews.com - April 5 at 12:56 PM
	The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, Pfizer, McDonald's and MetLife finance.yahoo.com - April 4 at 4:24 PM
	2-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MetLife, Inc. And Reminds Investors With Losses To Contact The Firm finance.yahoo.com - April 4 at 4:24 PM
	METLIFE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and ... www.businesswire.com - April 4 at 8:09 AM
	METLIFE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against MetLife, Inc. - MET finance.yahoo.com - April 4 at 8:09 AM
	Swiss Re (SSREY) versus MetLife (MET) Head to Head Contrast www.americanbankingnews.com - April 4 at 7:07 AM
	FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against MetLife, Inc. And Reminds Investors With Losses To Contact The Firm finance.yahoo.com - April 3 at 5:43 PM
	DEADLINE UPCOMING: The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of MetLife, Inc. Shareholders and a Lead Plaintiff Deadline of April 6, 2018 (MET) finance.yahoo.com - April 3 at 5:43 PM
	MetLife (MET) Rating Increased to Hold at Zacks Investment Research www.americanbankingnews.com - April 3 at 10:07 AM
	Glancy Prongay & Murray LLP Reminds Investors of the April 6, 2018 Deadline in the Class Action Lawsuit Against ... www.businesswire.com - April 3 at 8:09 AM
	TBWA's Lee Clow, Author Seth Godin and MetLife's Esther Lee Inducted Into American Marketing Association New ... www.businesswire.com - April 2 at 5:36 PM
	UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of MetLife, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 6, 2018 - MET finance.yahoo.com - April 2 at 5:36 PM
	FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In MetLife, Inc. (NYSE: MET) To Contact The Firm finance.yahoo.com - April 2 at 5:36 PM
	MetLife Investment Management Reaches $2.9 Billion of Global Agricultural Mortgage Production for 2017 finance.yahoo.com - April 2 at 5:36 PM

MetLife (NYSE:MET) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

MetLife (NYSE:MET) Income Statement, Balance Sheet and Cash Flow Statement

MetLife (NYSE MET) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff